Context Therapeutics Inc.
Pharmaceutical Preparations · PHILADELPHIA · PA
Moderate confidence (50%)
Updated Oct 10, 2026, 12:05 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: Context Therapeutics Inc. received a delisting notice from its exchange (Jul 29, 2026)
Timeline
Every material event, newest first. History is never overwritten.
Context Therapeutics Inc. received a delisting notice from its exchange
Jul 29, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On July 29, 2026, Context Therapeutics Inc. (the Company ) received written notice (the Notification Letter ) from the Nasdaq Listing Qualifications Department (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) stating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) (the Minimum Bid Price Rule ) because the Company s common stock failed to maintain a minimum closing bid price of $1.00 per share for 30 consecutive business days. The Notification Letter h…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker CNTX on Nasdaq.
- SEC CIK
- 0001842952
- Website
- —
- —
- Headquarters
- PHILADELPHIA, PA
- Also known as
- Context Therapeutics LLC
- Legal entities
- Context Therapeutics Inc.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
Context Therapeutics Inc. — Pharmaceutical Preparations (SIC 2834) — PHILADELPHIA, PA
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On July 29, 2026, Context Therapeutics Inc. (the Company ) received written notice (the Notification Letter ) from the Nasdaq Listing Qualifications Department (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) stating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) (the Minimum Bid Price Rule ) because the Company s common stock failed to maintain a minimum closing bid price of $1.00 per share for 30 consecutive business days. The Notification Letter h…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:31 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:14 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:33 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 13, 2026, 12:14 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:27 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.